Encrypted | Login

Radiopharmaceutical Therapy Subcommittee (RPTSC)

AAPM Members, Affiliates and Non-Member Affiliates - Login for access to additional information

Activities
  1. Consolidate, disseminate and maintain available information concerning RPT methodologies, dosimetry, science and practice.
  2. Establish structures needed for providing guidelines and Standard Operating Procedures (SOPs) for new and existing RPTs such as Task Groups, Working Groups or MPPGs.
  3. Take an active role in the education of the AAPM and general radiation oncology community regarding RPT methodologies and clinical practice.
  4. Coordinate with stakeholder groups within AAPM, advising them of overlaps and seeking mutual solutions where needed.  
  5. Coordinate with stakeholder groups outside of AAPM to develop uniform and effective approaches to common problems with regard to RPT. These may include: SNMMI, EANM, ASTRO, ESTRO, ICRU, IAEA, ICRP, ABS, NIST, FDA, IROC, NRC, DOE.
By-Laws:Not Referenced.Rules: Not Referenced.
Standing?This is not a standing committee.
Approved Date(s):2/25/2021
Committee Keywords: No Keywords Entered
Chair

Robert Hobbs
Subcommittee Chair

2025 Roster

(dates shown below are start and end dates of position.)

= complete and up-to-date
= up-to-date but expires soon
= incomplete or out of date conflict of interest statement.

VOTING AppointmentsThere are 18 voting members.

up-to-dateDenis Bergeron, PhD

1/1/2025 - 12/31/2027 Member

up-to-dateAlejandro Bertolet, PhD

10/7/2025 - 12/31/2028 Member

up-to-dateWesley E. Bolch, PhD

2/21/2025 - 12/31/2025 Chair,  Task Group No. 446: Technical guidance on patient hospital release of the radiop (ex officio)
2/25/2021 - 12/31/2026 Member

up-to-dateJessica Clements, MS

8/12/2025 - 12/31/2028 Member

up-to-dateYuni K. Dewaraja

5/15/2022 - 12/31/2026 Chair,  Task Group No. 381 - AAPM Recommendations on imaging, dosimetry and quality assu (ex officio)

up-to-dateStephen A. Graves Ph.D.

2/25/2021 - 12/31/2026 Member

up-to-dateRobert F. Hobbs, PhD

2/25/2021 - 12/31/2026 Subcommittee Chair

up-to-dateCarlos Huesa-Berral, PhD

10/7/2025 - 12/31/2028 Member

up-to-dateIan Marsh, PhD

1/1/2025 - 12/31/2027 Member

up-to-dateMelissa Carol Martin, MS

2/25/2021 - 12/31/2026 Member

up-to-dateNichole M. Maughan, PhD

10/7/2025 - 12/31/2027 Chair,  Task Group No. 454: Commissioning Radiopharmaceutical Therapy Dosimetry Software (ex officio)
8/12/2025 - 12/31/2028 Subcommittee Vice Chair

up-to-dateOsama R. Mawlawi, PhD

6/13/2023 - 12/31/2025 Member

up-to-dateCatherine (Caffi) Meyer, PhD

10/7/2025 - 12/31/2028 Member

up-to-dateZoubir Ouhib, MS

2/25/2021 - 12/31/2026 Member

up-to-dateReed G. Selwyn, PhD

5/25/2023 - 12/31/2025 Chair,  Working Group on Radioactive Microspheres (ex officio)

up-to-dateJohn Sunderland Ph.D.

10/7/2025 - 12/31/2028 Member

up-to-dateGerald A. White Jr., MS

10/7/2025 - 12/31/2028 Member

up-to-dateBrian E. Zimmerman

10/7/2025 - 12/31/2028 Member
NON-VOTING AppointmentsThere are 23 non-voting members and guests.

up-to-dateDavid P. Adam, PhD, MS

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateEthan Balkin

1/1/2022 - 12/31/2026 Liaison - DOE (nonvoting)

up-to-dateManuel Bardiès

10/2/2024 - 12/31/2025 Consultant - EFOMP Liaison (nonvoting)

up-to-dateJacek Capala, PhD

2/25/2021 - 12/31/2026 Liaison - NIH/NCI (ex officio, nonvoting)

up-to-dateKenneth W. Cashon, MS

1/30/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateShengwen Deng, PhD

10/7/2025 - 12/31/2026 Guest (nonvoting)

up-to-dateSven L. Gallo, MS

1/30/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateXiuxiu He, PhD

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateChun-Han Huang

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateJason C. Mace, PhD

1/30/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateJonathon W. Mueller, MS

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateXingyu Nie, PhD

3/19/2024 - 12/31/2025 Guest (nonvoting)

up-to-dateRobin Peter, PhD

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateBonnie N. President, PhD

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateEmilie Roncali

8/12/2025 - 12/31/2026 Guest (nonvoting)

up-to-dateSenthamizhchelvan Srinivasan, PhD

3/19/2024 - 12/31/2025 Guest (nonvoting)

up-to-dateShiv P. Srivastava, PhD

10/7/2025 - 12/31/2026 Guest (nonvoting)

up-to-dateKatherine N. Tapp, PhD

2/1/2022 - 12/31/2026 Liaison - NRC (nonvoting)

up-to-dateBrian C. Tom, PhD

1/30/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateYohan A. Walter, MS

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateYing Xiao, PhD

2/25/2021 - 12/31/2026 Liaison - IROC (ex officio, nonvoting)

up-to-dateHui Zhao, PhD

1/1/2025 - 12/31/2025 Guest (nonvoting)

up-to-dateJacqueline E. Zoberi, PhD

1/1/2025 - 12/31/2025 Guest (nonvoting)
HQ Team Appointed to CommitteeThere are 0 staff.



See connections to Radiopharmaceutical Therapy Subcommittee